PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 9:59 AM ET

Sponsor Check › Person

CY
No photo found yet (own website and image search run after this page is viewed)

Chen Yu

Named as an officer, director or promoter on SEC Form D filings · CA · Apr 13, 2009 → Oct 7, 2026

11deals (issuers)
$3.08Breported sold
249investors
25Form D filings
2009–2026years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:18 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Chen Yu is listed as an executive officer and director on 25 SEC Form D filings by 11 issuers between Apr 2009 and Oct 2026. Largest by amount reported sold: Vivo Capital Fund IX, L.P. (Palo Alto, CA — pooled investment fund — 2018–2019; $1.4B reported sold to 44 investors), TCG Crossover Fund I, L.P. (Palo Alto, CA — pooled investment fund — 2021; $800M reported sold to 79 investors), TCGX Asia Life Sciences Fund I, L.P. (Palo Alto, CA — pooled investment fund — 2026; $600M reported sold to 70 investors), ADARx Pharmaceuticals, Inc. (San Diego, CA — biotechnology — 2023; $200M reported sold to 28 investors), Sagent Holding Co. (Schaumburg, IL — pharmaceuticals — 2009–2010; $30M reported sold to 10 investors) and 6 more (all listed below).

What this means That is a lot of deals — 11 separate companies raised money with this person listed as executive officer and director, over about 17 years. Across those companies the filings report $3.08B sold in total.

Listed alongside Frank Kung (10 shared filings), Albert Cha (7 shared filings), Edgar Engleman (7 shared filings), Shan Fu (7 shared filings), David Schnell (6 shared filings) and 44 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Chen. Each name links to their own page.

2 of the issuers belong to the sponsor group Vivo (21 issuers, $4.22B reported sold, 2011–2026).

What this means A sponsor group is one team that sets up a new company for each deal. Vivo has 21 companies on file and $4.22B reported sold in total — the group page shows the whole track record in one place.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CO, CT, DC, DE, FINRA, FL, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, WA, WI, WV, WY) — 1 bankruptcy case matching the name listed in Key records below.

What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 25 public filings for Chen Yu and found 15 differences, 4 worth asking the sponsor about: Bankruptcy case: Chen Chen Yu; Amount sold went down between filings; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Chen Yu has not run yet — it is joining a line of 44,882 names; searches run around the clock at the hosts' allowed rate. Searched so far: 641 names.

Community comments are quoted as written by their authors. Sources searched: Bing (site:reddit.com / site:biggerpockets.com) and Reddit's own search, plus DuckDuckGo/Brave/BiggerPockets search when they are answering.

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:18 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: 48 regulators (FINRA, NASAA, 37 states) — crawled Oct 24, 2026, 8:48 AM ET

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Chen Yu..

State securities regulators: Securities regulators searched (64,910 actions): FINRA (38,350 actions, 1995–2026), NASAA (31 actions, 2000–2026; listing starts 1997), AK Division of Banking and Securities (273 actions, 1971–2025), AL Securities Commission (880 actions, 2001–2026), AR Securities Department (1,305 actions, 1998–2026), AZ Corporation Commission Securities Division (411 actions, 2017–2026), CA DFPI (25 actions, 2007–2024; listing starts 2002 — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), CO Division of Securities (731 actions, 2001–2026; older years from the Internet Archive (snapshot of 2026-05-02)), CT Department of Banking Securities Division (940 actions, 2006–2026; older years from the Internet Archive (snapshot of 2026-04-22)), DC DISB Securities Bureau (25 actions, 2012–2026), DE DOJ Investor Protection Unit (257 actions, 1987–2026), FL Office of Financial Regulation (49 actions, 2018–2026), GA Secretary of State Securities Division (65 actions, 2015–2026; listing starts 2012), HI DCCA Securities Enforcement Branch (26 actions, 2012–2026), ID Department of Finance Securities Bureau (663 actions, 1994–2026), IL Secretary of State Securities Department (4,122 actions, 2003–2023), KS Insurance Department Securities Division (58 actions), KY Department of Financial Institutions (342 actions, 2005–2026), LA Office of Financial Institutions Securities Division (13 actions, 2010–2025; listing starts 2008), MA Secretary of the Commonwealth Securities Division (125 actions, 2012–2025; live site blocks automated access — loaded from the Internet Archive snapshot of 2026-02-04), MD Attorney General Securities Division (1,054 actions, 2004–2026), ME Office of Securities (539 actions, 2000–2026), MI LARA Corporations, Securities & Commercial Licensing Bureau (201 actions), MO Secretary of State Securities Division (919 actions, 1998–2026), MS Secretary of State Securities Division (209 actions, 1995–2026), MT Commissioner of Securities and Insurance (597 actions, 2000–2026), NC Secretary of State Securities Division (265 actions, 2004–2024), ND Securities Department (711 actions, 1990–2026; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2026-01-06), NH Bureau of Securities Regulation (402 actions, 2002–2026), NM Regulation and Licensing Department Securities Division (90 actions, 2010–2025), NV Secretary of State Securities Division (118 actions, 2018–2026), NY Attorney General Investor Protection Bureau (44 actions, 2012–2026), OH Division of Securities (327 actions, 1993–2006), OK Department of Securities (2,531 actions, 1998–2026), OR Division of Financial Regulation (589 actions, 1988–2026), PA Department of Banking and Securities (1,448 actions, 2008–2024; the regulator no longer publishes this list live — loaded from the Internet Archive snapshot of 2024-08-09), RI DBR Securities Division (98 actions, 2005–2025), SC Attorney General Securities Division (540 actions, 2006–2026), SD Division of Insurance – Securities Regulation (106 actions, 2017–2026), TN Department of Commerce and Insurance Securities Division (405 actions, 1992–2026), TX State Securities Board (936 actions, 1999–2026), UT Division of Securities (772 actions, 2000–2026; older years from the Internet Archive (snapshot of 2010-05-27)), VT DFR Securities Division (137 actions, 2010–2026), WA DFI (2,039 actions, 2001–2026), WI DFI Division of Securities (1,072 actions, 1998–2026), WV Securities Commission (State Auditor) (64 actions), WY Secretary of State Compliance Division (6 actions, 2016–2024) — last crawled Oct 24, 2026, 8:48 AM ET. No machine-readable public listing today for IA, IN, MN, NE, NJ, VA (see docs/state-regulators.md).

3. Bankruptcies

1 case: 1 closed (disposition not in docket feed)

Chen Chen Yu closed
United States Bankruptcy Court, C.D. California · No. 2:13-bk-39537 · Filed Dec 17, 2013 · Closed Apr 8, 2014
Role of Chen Chen Yu: Debtor · Outcome: Case closed 2014-04-08 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (rare in federal dockets); 5 people with this name in Form D filings; court in the person's filing state (CA)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:18 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

15 differences found between the filings for Chen Yu — 4 worth asking about (compared 25 filings on Oct 24, 2026)

Worth asking · Dec 17, 2013 – Apr 8, 2014

Bankruptcy case: Chen Chen Yu — filed Dec 17, 2013

United States Bankruptcy Court, C.D. California docket "Chen Chen Yu" filed Dec 17, 2013, closed Apr 8, 2014. Chen Yu is listed as Debtor ("Chen Chen Yu"). Our match estimate: 58%.

What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.

Docket · United States Bankruptcy Court, C.D. California ↗
Sources
Note · Apr 8, 1999 – Jun 30, 2000

Bankruptcy case: Major Motor Supply Co Inc v. Krizman International Auto Parts — filed Apr 8, 1999

United States Bankruptcy Court, N.D. Illinois docket "Major Motor Supply Co Inc v. Krizman International Auto Parts" filed Apr 8, 1999, closed Jun 30, 2000. Anthony Krizman (listed on the same filings) is listed as Defendant ("Krizman International Auto Parts"). Our match estimate: 70%.

What this means A bankruptcy filing was found. Many are old or personal and have nothing to do with the deal — but ask what it was and when it closed.

Docket · United States Bankruptcy Court, N.D. Illinois ↗Anthony Krizman — PartnerFacts page ↗
Sources
Worth asking · Jun 2, 2009 – Apr 5, 2010

Amount sold went down between filings — Sagent Holding Co.

The Jun 2, 2009 filing says $30,000,000 sold; the Apr 5, 2010 Form D says $9,800,000 sold — $20,200,000 less.

What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.

Form D (earlier) · Jun 2, 2009 ↗Form D (later) · Apr 5, 2010 ↗Sagent Holding Co. — PartnerFacts page ↗
Sources
Worth asking · Jun 2, 2009 – Apr 5, 2010

Investor count went down between filings — Sagent Holding Co.

The Jun 2, 2009 filing reports 10 investors; the Apr 5, 2010 Form D reports 1 investor.

What this means Investor counts normally only grow. A smaller number can mean investors left or were refunded, or a count was corrected. Ask the sponsor what happened.

Form D (earlier) · Jun 2, 2009 ↗Form D (later) · Apr 5, 2010 ↗Sagent Holding Co. — PartnerFacts page ↗
Sources
Note · Jun 23, 2015 – Apr 6, 2023

Chen Yu appears on 2 deals that stopped filing before reaching their target

TCG Crossover Fund II, L.P. (last filing Apr 6, 2023; $0 sold of $900,000,000); Nexcida Therapeutics, Inc. (last filing Jun 23, 2015; $2,750,002 sold of $21,250,003). Each has no filing in more than two years and reported under half its target sold.

What this means An issuer whose last filing is more than two years old and reported under half its target sold. The raise may have closed early or quietly stopped. Ask what happened to each.

TCG Crossover Fund II, L.P. — PartnerFacts page ↗Nexcida Therapeutics, Inc. — PartnerFacts page ↗
Sources
Worth asking · Jan 23, 2019 – Oct 30, 2019

Paid seller listed without a CRD number: China Concept Consulting Ltd. — Vivo Capital Fund IX, L.P.

China Concept Consulting Ltd. is listed as receiving sales compensation on 4 filings (Jan 23, 2019 to Oct 30, 2019) with no FINRA CRD number given.

What this means People paid to sell securities normally hold a FINRA registration with a CRD number. Without one we cannot look them up on BrokerCheck. Ask who they are and whether they are registered.

Form D/A · Oct 30, 2019 ↗BrokerCheck search: China Concept Consulting Ltd. ↗Vivo Capital Fund IX, L.P. — PartnerFacts page ↗
Sources
Note · Sep 22, 2016 – Oct 18, 2016

Form D filed 26 days after the first sale — SentreHEART Inc

The filing says the first sale was Sep 22, 2016. The Form D was filed Oct 18, 2016 — 26 days later. The rule: a Form D is generally due within 15 days after the first sale, so this one is 11 days past that.

What this means A late notice is common and carries no penalty by itself. It is worth asking the sponsor why the paperwork lagged.

Form D · Oct 18, 2016 ↗SentreHEART Inc — PartnerFacts page ↗
Sources
Note · Mar 31, 2009 – Oct 18, 2016

5 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — SentreHEART Inc (latest filing Oct 18, 2016) · No amendment in the last 12 months on an offering that may still be open — Nora Therapeutics, Inc. (latest filing Oct 13, 2015) · No amendment in the last 12 months on an offering that may still be open — Nexcida Therapeutics, Inc. (latest filing Jun 23, 2015) · No amendment in the last 12 months on an offering that may still be open — Nora Therapeutics, Inc. (latest filing Sep 23, 2010) · No amendment in the last 12 months on an offering that may still be open — Nora Therapeutics, Inc. (latest filing Jun 2, 2010)

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · Oct 18, 2016 ↗SentreHEART Inc — PartnerFacts page ↗Form D · Oct 13, 2015 ↗Nora Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Apr 13, 2009 – Oct 7, 2026

5 offerings changed their target amount between filings

Offering amount changed between filings — TCGX Asia Life Sciences Fund I, L.P. · Offering amount changed between filings — TCG Crossover Fund I, L.P. · Offering amount changed between filings — Vivo Capital Fund IX, L.P. · Offering amount changed between filings — Nora Therapeutics, Inc. · Offering amount lowered between filings — Sagent Holding Co.

What this means Targets change as deals grow or shrink. Ask whether later money has the same terms.

Form D (earlier) · Jul 29, 2026 ↗Form D/A (later) · Oct 7, 2026 ↗TCGX Asia Life Sciences Fund I, L.P. — PartnerFacts page ↗Form D (earlier) · Jan 14, 2021 ↗
Sources
Note · Apr 13, 2009 – Jun 2, 2010

Minimum investment changed between filings — Nora Therapeutics, Inc.

The Apr 13, 2009 filing lists a minimum of $16,291; the Jun 2, 2010 Form D/A lists $919.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D (earlier) · Apr 13, 2009 ↗Form D/A (later) · Jun 2, 2010 ↗Nora Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Apr 13, 2009 – Apr 23, 2014

Reported revenue range changed between filings — Nora Therapeutics, Inc.

"No Revenues" (Apr 13, 2009); then "Decline to Disclose" (Apr 23, 2014).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Apr 13, 2009 ↗Form D · Apr 23, 2014 ↗Nora Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Jan 10, 2024

Same name, different state: "Chen Yu" (NY) is a separate record

This page covers filings where the address state is CA. A separate record, "Chen Yu" with address state NY, is listed on 1 filing — most recently by LB PHARMACEUTICALS INC (Jan 10, 2024). Both records have filings in the same period (Jan 10, 2024).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Chen Yu (NY) — PartnerFacts page ↗Form D/A · Jan 10, 2024 ↗LB PHARMACEUTICALS INC — PartnerFacts page ↗Chen Yu (CA) — this page ↗
Sources
Note · Mar 29, 2016 – Nov 10, 2021

Same name, different state: "Chen Yu" (MA) is a separate record

This page covers filings where the address state is CA. A separate record, "Chen Yu" with address state MA, is listed on 4 filings — most recently by Arbor Biotechnologies, Inc. (Nov 10, 2021). Both records have filings in the same period (Mar 29, 2016 to Nov 10, 2021).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Chen Yu (MA) — PartnerFacts page ↗Form D · Nov 10, 2021 ↗Arbor Biotechnologies, Inc. — PartnerFacts page ↗Chen Yu (CA) — this page ↗
Sources
Note · Oct 12, 2018

Same name, different state: "Chen Yu" (IN) is a separate record

This page covers filings where the address state is CA. A separate record, "Chen Yu" with address state IN, is listed on 1 filing — most recently by Outpost Medicine, LLC (Oct 12, 2018). Both records have filings in the same period (Oct 12, 2018).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Chen Yu (IN) — PartnerFacts page ↗Form D/A · Oct 12, 2018 ↗Outpost Medicine, LLC — PartnerFacts page ↗Chen Yu (CA) — this page ↗
Sources
Note · Jun 2, 2010 – Sep 23, 2010

Address moved from Owing Mills, MD to Palo Alto, CA — Nora Therapeutics, Inc.

The people listed on the Jun 2, 2010 filing give Owing Mills, MD; on the Sep 23, 2010 filing they give Palo Alto, CA. The address now on file (530 Lytton Avenue, 2nd Floor, Palo Alto, CA) is a registered-agent or shared-office address used by 39 issuers.

What this means A registered agent's address is a mailbox, not where the team works. Ask where the business actually operates.

Form D/A · Jun 2, 2010 ↗Form D · Sep 23, 2010 ↗Nora Therapeutics, Inc. — PartnerFacts page ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

1 of 16 offerings reports sales commissions totalling $10,321,136; 0 report finder's fees; 0 report proceeds to related persons.

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Oct 7, 2026 D/A
TCGX Asia Life Sciences Fund I, L.P.
File 021-592516
$0$0$0None listed on this filingEDGAR ↗
Jun 26, 2025 D
TCG Crossover Fund III, L.P.
File 021-550055
$0$0$0None listed on this filingEDGAR ↗
Aug 10, 2023 D
ADARx Pharmaceuticals, Inc.
File 021-489353
$0$0$0None listed on this filingEDGAR ↗
Apr 6, 2023 D
TCG Crossover Fund II, L.P.
File 021-478183
$0$0$0None listed on this filingEDGAR ↗
Apr 14, 2021 D/A
TCG Crossover Fund I, L.P.
File 021-386412
$0$0$0None listed on this filingEDGAR ↗
Oct 30, 2019 D/A
Vivo Capital Fund IX, L.P.
File 021-319413
$10,321,136$0$0Probitas Funds Group, LLC BrokerCheck CRD 115876 ↗
via Probitas Funds Group, LLC (CRD 115876 ↗)

China Concept Consulting Ltd. no CRD number reported
Gold Eagle Enterprises Limited BrokerCheck CRD 677370 ↗
Goldman Sachs & Co. LLC BrokerCheck CRD 361 ↗
via Goldman Sachs & Co. LLC (CRD 361 ↗)

XT Capital Partners, LLC BrokerCheck CRD 118719 ↗
via XT Capital Partners, LLC (CRD 118719 ↗)
EDGAR ↗
Sep 27, 2019 D
Vivo Capital Fund IX E&F, L.P.
File 021-349902
$0$0$0None listed on this filingEDGAR ↗
Oct 18, 2016 D
SentreHEART Inc
File 021-272697
$0$0$0
The Issuer will use proceeds for general working capital purposes which includes payments to its executive officers and other employees in the ordinary course of business.
None listed on this filingEDGAR ↗
Oct 13, 2015 D
Nora Therapeutics, Inc.
File 021-249197
$0$0$0None listed on this filingEDGAR ↗
Jun 23, 2015 D
Nexcida Therapeutics, Inc.
File 021-242328
$0$0$0None listed on this filingEDGAR ↗
May 14, 2015 D
Nora Therapeutics, Inc.
File 021-239899
$0$0$0None listed on this filingEDGAR ↗
Apr 23, 2014 D
Nora Therapeutics, Inc.
File 021-216080
$0$0$0None listed on this filingEDGAR ↗
Sep 23, 2010 D
Nora Therapeutics, Inc.
File 021-148095
$0$0$0None listed on this filingEDGAR ↗
Sep 14, 2010 D
Sagent Holding Co.
File 021-147701
$0$0$0None listed on this filingEDGAR ↗
Jun 2, 2010 D/A
Nora Therapeutics, Inc.
File 021-130159
$0$0$0None listed on this filingEDGAR ↗
Apr 5, 2010 D
Sagent Holding Co.
File 021-92177
$0$0$0None listed on this filingEDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 11

Every issuer that named Chen Yu on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

TA
Pooled Investment Fund

TCGX Asia Life Sciences Fund I, L.P.

Palo Alto, CA · Jul 29, 2026 → Oct 7, 2026 · 2 filings
  • Oct 7, 2026 · D/A · $600,000,000 sold of $600,000,000 · 70 investors · min. No minimum reported · role: Director (Director of the Ultimate General Partner) EDGAR ↗
  • Jul 29, 2026 · D · $0 sold of $400,000,000 · 0 investors · min. No minimum reported · role: Director (Director of the Ultimate General Partner) EDGAR ↗

Raised $600M from 70 investors (100% of the $600M target) as of the latest filing. Chen is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

TC
Pooled Investment Fund

TCG Crossover Fund III, L.P.

Palo Alto, CA · Jun 26, 2025
  • Jun 26, 2025 · D · $0 sold of $1,200,000,000 · 0 investors · min. No minimum reported · role: Executive Officer (Managing Member of the General Partner) EDGAR ↗

No sales reported yet as of the latest filing. Chen is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AP
Biotechnology

ADARx Pharmaceuticals, Inc.

San Diego, CA · Aug 10, 2023
  • Aug 10, 2023 · D · $200,000,012 sold of $200,000,012 · 28 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $200M from 28 investors (100% of the $200M target) as of the latest filing. Chen is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

TC
Pooled Investment Fund

TCG Crossover Fund II, L.P.

Palo Alto, CA · Apr 6, 2023
  • Apr 6, 2023 · D · $0 sold of $900,000,000 · 0 investors · min. No minimum reported · role: Executive Officer (Managing Member of the General Partner) EDGAR ↗

No sales reported yet as of the latest filing. Chen is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

TC
Pooled Investment Fund

TCG Crossover Fund I, L.P.

Palo Alto, CA · Jan 14, 2021 → Apr 14, 2021 · 2 filings
  • Apr 14, 2021 · D/A · $800,000,000 sold of $800,000,000 · 79 investors · min. No minimum reported · role: Executive Officer (Managing Member of the General Partner) EDGAR ↗
  • Jan 14, 2021 · D · $0 sold of $700,000,000 · 0 investors · min. No minimum reported · role: Executive Officer (Managing Member of the General Partner) EDGAR ↗

Raised $800M from 79 investors (100% of the $800M target) as of the latest filing. Chen is listed as executive officer on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

VC
Pooled Investment Fund · group: Vivo

Vivo Capital Fund IX, L.P.

Palo Alto, CA · Aug 16, 2018 → Oct 30, 2019 · 6 filings
  • Oct 30, 2019 · D/A · $1,401,787,761 sold of $1,401,787,761 · 44 investors · min. No minimum reported · role: Director (Managing Member of the General Partner) EDGAR ↗
  • Aug 12, 2019 · D/A · $1,304,978,261 sold of Indefinite · 38 investors · min. No minimum reported · role: Director (Managing Member of the General Partner) EDGAR ↗
  • Jun 3, 2019 · D/A · $1,280,978,261 sold of Indefinite · 36 investors · min. No minimum reported · role: Director (Managing Member of the General Partner) EDGAR ↗
  • Jan 23, 2019 · D/A · $863,978,261 sold of Indefinite · 29 investors · min. No minimum reported · role: Director (Managing Member of the General Partner) EDGAR ↗
  • Dec 6, 2018 · D/A · $863,978,261 sold of Indefinite · 29 investors · min. No minimum reported · role: Director (Managing Member of the General Partner) EDGAR ↗
  • Aug 16, 2018 · D · $0 sold of Indefinite · 0 investors · min. No minimum reported · role: Director (Managing Member of the General Partner) EDGAR ↗

Raised $1.4B from 44 investors (100% of the $1.4B target) as of the latest filing. Chen is listed as director on 6 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

VC
Pooled Investment Fund · group: Vivo

Vivo Capital Fund IX E&F, L.P.

Palo Alto, CA · Sep 27, 2019
  • Sep 27, 2019 · D · $0 sold of Indefinite · 0 investors · min. No minimum reported · role: Executive Officer (Managing Member of the General Partner) EDGAR ↗

No sales reported yet as of the latest filing. Chen is listed as executive officer.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pooled Investment Fund / 506(b) (83,801 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

S
Biotechnology

SentreHEART Inc

Redwood City, CA · Oct 18, 2016
  • Oct 18, 2016 · D · $25,000,000 sold of $35,000,000 · 7 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $26M from 7 investors (74% of the $35M target) as of the latest filing. Chen is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

NT
Biotechnology

Nora Therapeutics, Inc.

Palo Alto, CA · Apr 13, 2009 → Oct 13, 2015 · 6 filings
  • Oct 13, 2015 · D · $1,000,000 sold of $3,000,000 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 14, 2015 · D · $0 sold of $536,709 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 23, 2014 · D · $18,000,000 sold of $18,000,000 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 23, 2010 · D · $14,880,000 sold of $32,554,999 · 5 investors · min. $12,950 · role: Director EDGAR ↗
  • Jun 2, 2010 · D/A · $2,932,000 sold of $25,137,000 · 4 investors · min. $919 · role: Director EDGAR ↗
  • Apr 13, 2009 · D · $1,000,000 sold of $24,000,000 · 4 investors · min. $16,291 · role: Director EDGAR ↗

Raised $18M from 6 investors (100% of the $3M target) as of the latest filing. Chen is listed as director on 6 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

NT
Other

Nexcida Therapeutics, Inc.

Menlo Park, CA · Jun 23, 2015
  • Jun 23, 2015 · D · $2,750,002 sold of $21,250,003 · 5 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $2.75M from 5 investors (13% of the $21.3M target) as of the latest filing. Chen is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other / 506(b) (18,678 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

SH
Pharmaceuticals

Sagent Holding Co.

Schaumburg, IL · Jun 2, 2009 → Sep 14, 2010 · 3 filings
  • Sep 14, 2010 · D · $5,999,998 sold of $5,999,998 · 2 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 5, 2010 · D · $9,800,000 sold of $9,800,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 2, 2009 · D · $30,000,000 sold of $30,000,000 · 10 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $30M from 10 investors (100% of the $6M target) as of the latest filing. Chen is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

Other pages with the same name (4)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Chen Yu — MA, 3 issuers, Mar 29, 2016 → Nov 10, 2021 · no shared issuer
  • Chen Ming Yu — CA, 2 issuers, Jan 13, 2011 → Jan 10, 2022 · no shared issuer
  • Chen Yu — IN, 1 issuer, Oct 12, 2018 → Oct 12, 2018 · no shared issuer
  • Chen Yu — NY, 1 issuer, Jan 10, 2024 → Jan 10, 2024 · no shared issuer

People around Chen 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

VC
Management entity

Vivo Capital IX, LLC

Promoter · 6 shared filings (1 issuer)

Listed on the same filings as Chen Yu. Their page shows their other deals.

VC
Management entity

Vivo Capital IX (Cayman), LLC

Promoter · 1 shared filing (1 issuer)

Listed on the same filings as Chen Yu. Their page shows their other deals.

FK
No photo found yet (own website and image search run after this page is viewed)
Person

Frank Kung

Director, Executive Officer · 10 shared filings (3 issuers) · also on 21 other issuers

Frank Kung is on 24 issuers in total — a repeat sponsor. Their page lists every one.

SF
No photo found yet (own website and image search run after this page is viewed)
Person

Shan Fu

Director, Executive Officer · 7 shared filings (2 issuers) · also on 9 other issuers

Shan Fu is on 11 issuers in total — a repeat sponsor. Their page lists every one.

AC
No photo found yet (own website and image search run after this page is viewed)
Person

Albert Cha

Director, Executive Officer · 7 shared filings (2 issuers) · also on 17 other issuers

Albert Cha is on 19 issuers in total — a repeat sponsor. Their page lists every one.

EE
No photo found yet (own website and image search run after this page is viewed)
Person

Edgar Engleman

Director, Executive Officer · 7 shared filings (2 issuers) · also on 13 other issuers

Edgar Engleman is on 15 issuers in total — a repeat sponsor. Their page lists every one.

DH
No photo found yet (own website and image search run after this page is viewed)
Person

Donald J. Hayden

Director · 6 shared filings (1 issuer) · also on 4 other issuers

Donald J. Hayden is on 5 issuers in total — a repeat sponsor. Their page lists every one.

DS
No photo found yet (own website and image search run after this page is viewed)
Person

David Schnell

Director · 6 shared filings (1 issuer) · also on 8 other issuers

David Schnell is on 9 issuers in total — a repeat sponsor. Their page lists every one.

MV
No photo found yet (own website and image search run after this page is viewed)
Person

Martin Vogelbaum

Director · 4 shared filings (1 issuer) · also on 8 other issuers

Martin Vogelbaum is on 9 issuers in total — a repeat sponsor. Their page lists every one.

BF
No photo found yet (own website and image search run after this page is viewed)
Person

Bryant E. Fong

Director · 4 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Chen Yu. Their page shows their other deals.

JT
No photo found yet (own website and image search run after this page is viewed)
Person

Jeffrey K. Tong

Executive Officer, Director · 4 shared filings (1 issuer)

Listed on the same filings as Chen Yu. Their page shows their other deals.

RP
No photo found yet (own website and image search run after this page is viewed)
Person

Ronald Pauli

Executive Officer · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Chen Yu. Their page shows their other deals.

JY
No photo found yet (own website and image search run after this page is viewed)
Person

Jeffrey Yordon

Executive Officer, Director · 3 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Chen Yu. Their page shows their other deals.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

James Sperans

Director · 3 shared filings (1 issuer) · also on 27 other issuers

James Sperans is on 28 issuers in total — a repeat sponsor. Their page lists every one.

DC
No photo found yet (own website and image search run after this page is viewed)
Person

Darryl L. Carter

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Chen Yu. Their page shows their other deals.

CM
No photo found yet (own website and image search run after this page is viewed)
Person

Christopher B. McClain

Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Chen Yu. Their page shows their other deals.

DF
No photo found yet (own website and image search run after this page is viewed)
Person

Dennis Fenton

Director · 3 shared filings (1 issuer) · also on 5 other issuers

Dennis Fenton is on 6 issuers in total — a repeat sponsor. Their page lists every one.

RF
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Flanagan

Director · 3 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Chen Yu. Their page shows their other deals.

JT
No photo found yet (own website and image search run after this page is viewed)
Person

Joseph L. Turner

Director · 2 shared filings (1 issuer) · also on 5 other issuers

Joseph L. Turner is on 6 issuers in total — a repeat sponsor. Their page lists every one.

AD
No photo found yet (own website and image search run after this page is viewed)
Person

Anupam Dalal

Director · 2 shared filings (1 issuer) · also on 8 other issuers

Anupam Dalal is on 9 issuers in total — a repeat sponsor. Their page lists every one.

CG
No photo found yet (own website and image search run after this page is viewed)
Person

Carl L. Gordon

Director · 1 shared filing (1 issuer) · also on 61 other issuers

Carl L. Gordon is on 62 issuers in total — a repeat sponsor. Their page lists every one.

LK
No photo found yet (own website and image search run after this page is viewed)
Person

Lorence Kim

Director · 1 shared filing (1 issuer) · also on 6 other issuers

Lorence Kim is on 7 issuers in total — a repeat sponsor. Their page lists every one.

RF
No photo found yet (own website and image search run after this page is viewed)
Person

Richard Ferrari

Director · 1 shared filing (1 issuer) · also on 16 other issuers

Richard Ferrari is on 17 issuers in total — a repeat sponsor. Their page lists every one.

AC
No photo found yet (own website and image search run after this page is viewed)
Person

Alan Colowick

Executive Officer, Director · 1 shared filing (1 issuer) · also on 9 other issuers

Alan Colowick is on 10 issuers in total — a repeat sponsor. Their page lists every one.

SG
No photo found yet (own website and image search run after this page is viewed)
Person

Simeon George

Director · 1 shared filing (1 issuer) · also on 32 other issuers

Simeon George is on 33 issuers in total — a repeat sponsor. Their page lists every one.

RH
No photo found yet (own website and image search run after this page is viewed)
Person

Russell Hirsch

Director · 1 shared filing (1 issuer) · also on 11 other issuers

Russell Hirsch is on 12 issuers in total — a repeat sponsor. Their page lists every one.

JM
No photo found yet (own website and image search run after this page is viewed)
Person

Julie McHugh

Executive Officer, Director · 1 shared filing (1 issuer)

Listed on the same filings as Chen Yu. Their page shows their other deals.

BA
No photo found yet (own website and image search run after this page is viewed)
Person

Brent Ahrens

Director · 1 shared filing (1 issuer) · also on 10 other issuers

Brent Ahrens is on 11 issuers in total — a repeat sponsor. Their page lists every one.

CT
No photo found yet (own website and image search run after this page is viewed)
Person

Casey Tansey

Director · 1 shared filing (1 issuer) · also on 25 other issuers

Casey Tansey is on 26 issuers in total — a repeat sponsor. Their page lists every one.

AK
No photo found yet (own website and image search run after this page is viewed)
Person

Anthony Krizman

Director · 1 shared filing (1 issuer)

Listed on the same filings as Chen Yu. Their page shows their other deals.

MQ
No photo found yet (own website and image search run after this page is viewed)
Person

Mark Qiu

Director · 1 shared filing (1 issuer)

Listed on the same filings as Chen Yu. Their page shows their other deals.

YG
No photo found yet (own website and image search run after this page is viewed)
Person

Yigong (James) Ge

Director · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Chen Yu. Their page shows their other deals.

DS
No photo found yet (own website and image search run after this page is viewed)
Person

David Socks

Executive Officer, Director, Promoter · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Chen Yu. Their page shows their other deals.

PY
No photo found yet (own website and image search run after this page is viewed)
Person

Phil Young

Director · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Chen Yu. Their page shows their other deals.

SG
No photo found yet (own website and image search run after this page is viewed)
Person

Sheila Gujrathi

Director · 1 shared filing (1 issuer) · also on 5 other issuers

Sheila Gujrathi is on 6 issuers in total — a repeat sponsor. Their page lists every one.

EC
No photo found yet (own website and image search run after this page is viewed)
Person

Erez Chimovits

Director · 1 shared filing (1 issuer) · also on 10 other issuers

Erez Chimovits is on 11 issuers in total — a repeat sponsor. Their page lists every one.

VT
No photo found yet (own website and image search run after this page is viewed)
Person

Victor Tong

Director · 1 shared filing (1 issuer) · also on 5 other issuers

Victor Tong is on 6 issuers in total — a repeat sponsor. Their page lists every one.

RS
No photo found yet (own website and image search run after this page is viewed)
Person

Russell Seiber

Executive Officer, Director · 1 shared filing (1 issuer)

Listed on the same filings as Chen Yu. Their page shows their other deals.

TH
No photo found yet (own website and image search run after this page is viewed)
Person

Theodore Huber

Director · 1 shared filing (1 issuer)

Listed on the same filings as Chen Yu. Their page shows their other deals.

PS
No photo found yet (own website and image search run after this page is viewed)
Person

Pam Simons

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Chen Yu. Their page shows their other deals.

The team behind the deals

V
Sponsor group

Vivo

21 issuers · 41 filings · $4.22B reported sold · 2011–2026

One team, 21 deal companies. Chen Yu is listed on 2 of them.

Sources

Issuers are grouped when their Form D filings share related persons, a management entity or a business address (automatic match from the filings). "Listed" marks the issuers that name Chen Yu.

Same business address

51 other issuers file from the same address (first 50 shown)

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Business registration (state registry / Secretary of State)

Individuals are not matched to business registrations — registries list companies, and a name alone is not enough to tie a person to one. Officers and managers appear by name inside each matched company's record on the issuer pages. Registries searched: AL (Alabama Secretary of State — Business Entity Records (arc-sos.state.al.us), searched by issuer name, data as of Oct 24, 2026); CO (Colorado Secretary of State — Business Entities in Colorado (data.colorado.gov), data as of Oct 23, 2026); CT (Connecticut Secretary of the State — Business Registry (data.ct.gov), data as of Oct 24, 2026); FL (Florida Department of State, Division of Corporations — quarterly corporate data file (Sunbiz), data as of Oct 7, 2026); NY (New York Department of State — Corporations and Other Entities (data.ny.gov: All Filings + Active Corporations), data as of Oct 20, 2026); OR (Oregon Secretary of State — Active Businesses, All (data.oregon.gov), data as of Oct 20, 2026); PA (Pennsylvania Department of State — Registered Businesses, Current (data.pa.gov), data as of Oct 6, 2026); TX (Texas Comptroller — Active Franchise Taxpayers incl. Secretary of State file data (data.texas.gov), data as of Oct 24, 2026). Registries of other states have not been searched: many publish no bulk file and require a CAPTCHA or bot challenge on their search page, which we do not bypass (Delaware, for example, offers no public bulk file).

Adviser registration (Form ADV)

None of the 11 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Chen Yu by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 11 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Chen Yu is listed on: none on file. No website or social profile named in ADARx Pharmaceuticals, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #119,100 of 374,652 in line (1,386 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (San Diego, CA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗California — find the county court ↗Los Angeles Superior Court case search ↗Cook County Clerk of Court case search ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

California Secretary of State business search ↗Illinois Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Chen Yu appears on a new Form D, or when a court case or SEC action is matched to them. See plans →